Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma (Q37847011)
Jump to navigation
Jump to search
scientific article published on 24 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma |
scientific article published on 24 February 2011 |
Statements
1 reference
Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma. (English)
1 reference
Joong-Won Park
1 reference
Richard S Finn
1 reference
Jun Suk Kim
1 reference
Ruby K Li
1 reference
Fuad Ismail
1 reference
Melanie Thomas
1 reference
Rosemarie Harris
1 reference
Christine Baudelet
1 reference
Ian Walters
1 reference
Jean-Luc Raoul
1 reference
24 February 2011
1 reference
1 reference
Identifiers
1 reference